Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Psychedelic Drugs
1.2 Key Market Segments
1.2.1 Psychedelic Drugs Segment by Type
1.2.2 Psychedelic Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Psychedelic Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Psychedelic Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Psychedelic Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Psychedelic Drugs Market Competitive Landscape
3.1 Global Psychedelic Drugs Sales by Manufacturers (2019-2024)
3.2 Global Psychedelic Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Psychedelic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Psychedelic Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Psychedelic Drugs Sales Sites, Area Served, Product Type
3.6 Psychedelic Drugs Market Competitive Situation and Trends
3.6.1 Psychedelic Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Psychedelic Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Psychedelic Drugs Industry Chain Analysis
4.1 Psychedelic Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Psychedelic Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Psychedelic Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Psychedelic Drugs Sales Market Share by Type (2019-2024)
6.3 Global Psychedelic Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Psychedelic Drugs Price by Type (2019-2024)
7 Psychedelic Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Psychedelic Drugs Market Sales by Application (2019-2024)
7.3 Global Psychedelic Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Psychedelic Drugs Sales Growth Rate by Application (2019-2024)
8 Psychedelic Drugs Market Segmentation by Region
8.1 Global Psychedelic Drugs Sales by Region
8.1.1 Global Psychedelic Drugs Sales by Region
8.1.2 Global Psychedelic Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Psychedelic Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Psychedelic Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Psychedelic Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Psychedelic Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Psychedelic Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 COMPASS Pathways PLC
9.1.1 COMPASS Pathways PLC Psychedelic Drugs Basic Information
9.1.2 COMPASS Pathways PLC Psychedelic Drugs Product Overview
9.1.3 COMPASS Pathways PLC Psychedelic Drugs Product Market Performance
9.1.4 COMPASS Pathways PLC Business Overview
9.1.5 COMPASS Pathways PLC Psychedelic Drugs SWOT Analysis
9.1.6 COMPASS Pathways PLC Recent Developments
9.2 Pfizer
9.2.1 Pfizer Psychedelic Drugs Basic Information
9.2.2 Pfizer Psychedelic Drugs Product Overview
9.2.3 Pfizer Psychedelic Drugs Product Market Performance
9.2.4 Pfizer Business Overview
9.2.5 Pfizer Psychedelic Drugs SWOT Analysis
9.2.6 Pfizer Recent Developments
9.3 Eli Lilly
9.3.1 Eli Lilly Psychedelic Drugs Basic Information
9.3.2 Eli Lilly Psychedelic Drugs Product Overview
9.3.3 Eli Lilly Psychedelic Drugs Product Market Performance
9.3.4 Eli Lilly Psychedelic Drugs SWOT Analysis
9.3.5 Eli Lilly Business Overview
9.3.6 Eli Lilly Recent Developments
9.4 GlaxoSmithKline
9.4.1 GlaxoSmithKline Psychedelic Drugs Basic Information
9.4.2 GlaxoSmithKline Psychedelic Drugs Product Overview
9.4.3 GlaxoSmithKline Psychedelic Drugs Product Market Performance
9.4.4 GlaxoSmithKline Business Overview
9.4.5 GlaxoSmithKline Recent Developments
9.5 Cybin Inc
9.5.1 Cybin Inc Psychedelic Drugs Basic Information
9.5.2 Cybin Inc Psychedelic Drugs Product Overview
9.5.3 Cybin Inc Psychedelic Drugs Product Market Performance
9.5.4 Cybin Inc Business Overview
9.5.5 Cybin Inc Recent Developments
9.6 Field Trip Health
9.6.1 Field Trip Health Psychedelic Drugs Basic Information
9.6.2 Field Trip Health Psychedelic Drugs Product Overview
9.6.3 Field Trip Health Psychedelic Drugs Product Market Performance
9.6.4 Field Trip Health Business Overview
9.6.5 Field Trip Health Recent Developments
9.7 ATAI Life Sciences
9.7.1 ATAI Life Sciences Psychedelic Drugs Basic Information
9.7.2 ATAI Life Sciences Psychedelic Drugs Product Overview
9.7.3 ATAI Life Sciences Psychedelic Drugs Product Market Performance
9.7.4 ATAI Life Sciences Business Overview
9.7.5 ATAI Life Sciences Recent Developments
9.8 NUMINUS WELLNESS
9.8.1 NUMINUS WELLNESS Psychedelic Drugs Basic Information
9.8.2 NUMINUS WELLNESS Psychedelic Drugs Product Overview
9.8.3 NUMINUS WELLNESS Psychedelic Drugs Product Market Performance
9.8.4 NUMINUS WELLNESS Business Overview
9.8.5 NUMINUS WELLNESS Recent Developments
9.9 MindMed
9.9.1 MindMed Psychedelic Drugs Basic Information
9.9.2 MindMed Psychedelic Drugs Product Overview
9.9.3 MindMed Psychedelic Drugs Product Market Performance
9.9.4 MindMed Business Overview
9.9.5 MindMed Recent Developments
9.10 HAVN Life Sciences
9.10.1 HAVN Life Sciences Psychedelic Drugs Basic Information
9.10.2 HAVN Life Sciences Psychedelic Drugs Product Overview
9.10.3 HAVN Life Sciences Psychedelic Drugs Product Market Performance
9.10.4 HAVN Life Sciences Business Overview
9.10.5 HAVN Life Sciences Recent Developments
9.11 Seelos Therapeutics
9.11.1 Seelos Therapeutics Psychedelic Drugs Basic Information
9.11.2 Seelos Therapeutics Psychedelic Drugs Product Overview
9.11.3 Seelos Therapeutics Psychedelic Drugs Product Market Performance
9.11.4 Seelos Therapeutics Business Overview
9.11.5 Seelos Therapeutics Recent Developments
9.12 Jannsen
9.12.1 Jannsen Psychedelic Drugs Basic Information
9.12.2 Jannsen Psychedelic Drugs Product Overview
9.12.3 Jannsen Psychedelic Drugs Product Market Performance
9.12.4 Jannsen Business Overview
9.12.5 Jannsen Recent Developments
9.13 Acadia Pharmaceuticals
9.13.1 Acadia Pharmaceuticals Psychedelic Drugs Basic Information
9.13.2 Acadia Pharmaceuticals Psychedelic Drugs Product Overview
9.13.3 Acadia Pharmaceuticals Psychedelic Drugs Product Market Performance
9.13.4 Acadia Pharmaceuticals Business Overview
9.13.5 Acadia Pharmaceuticals Recent Developments
9.14 Intellipharmaceutics
9.14.1 Intellipharmaceutics Psychedelic Drugs Basic Information
9.14.2 Intellipharmaceutics Psychedelic Drugs Product Overview
9.14.3 Intellipharmaceutics Psychedelic Drugs Product Market Performance
9.14.4 Intellipharmaceutics Business Overview
9.14.5 Intellipharmaceutics Recent Developments
9.15 Revive Therapeutics
9.15.1 Revive Therapeutics Psychedelic Drugs Basic Information
9.15.2 Revive Therapeutics Psychedelic Drugs Product Overview
9.15.3 Revive Therapeutics Psychedelic Drugs Product Market Performance
9.15.4 Revive Therapeutics Business Overview
9.15.5 Revive Therapeutics Recent Developments
9.16 Mydecine Innovations Group
9.16.1 Mydecine Innovations Group Psychedelic Drugs Basic Information
9.16.2 Mydecine Innovations Group Psychedelic Drugs Product Overview
9.16.3 Mydecine Innovations Group Psychedelic Drugs Product Market Performance
9.16.4 Mydecine Innovations Group Business Overview
9.16.5 Mydecine Innovations Group Recent Developments
9.17 Red Light Holland
9.17.1 Red Light Holland Psychedelic Drugs Basic Information
9.17.2 Red Light Holland Psychedelic Drugs Product Overview
9.17.3 Red Light Holland Psychedelic Drugs Product Market Performance
9.17.4 Red Light Holland Business Overview
9.17.5 Red Light Holland Recent Developments
9.18 Braxia Scientific
9.18.1 Braxia Scientific Psychedelic Drugs Basic Information
9.18.2 Braxia Scientific Psychedelic Drugs Product Overview
9.18.3 Braxia Scientific Psychedelic Drugs Product Market Performance
9.18.4 Braxia Scientific Business Overview
9.18.5 Braxia Scientific Recent Developments
9.19 Mind Cure Health
9.19.1 Mind Cure Health Psychedelic Drugs Basic Information
9.19.2 Mind Cure Health Psychedelic Drugs Product Overview
9.19.3 Mind Cure Health Psychedelic Drugs Product Market Performance
9.19.4 Mind Cure Health Business Overview
9.19.5 Mind Cure Health Recent Developments
9.20 Entheon Biomedical
9.20.1 Entheon Biomedical Psychedelic Drugs Basic Information
9.20.2 Entheon Biomedical Psychedelic Drugs Product Overview
9.20.3 Entheon Biomedical Psychedelic Drugs Product Market Performance
9.20.4 Entheon Biomedical Business Overview
9.20.5 Entheon Biomedical Recent Developments
10 Psychedelic Drugs Market Forecast by Region
10.1 Global Psychedelic Drugs Market Size Forecast
10.2 Global Psychedelic Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Psychedelic Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Psychedelic Drugs Market Size Forecast by Region
10.2.4 South America Psychedelic Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Psychedelic Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Psychedelic Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Psychedelic Drugs by Type (2025-2030)
11.1.2 Global Psychedelic Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Psychedelic Drugs by Type (2025-2030)
11.2 Global Psychedelic Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Psychedelic Drugs Sales (K Units) Forecast by Application
11.2.2 Global Psychedelic Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
